Erin Lavery, from Scotland, was diagnosed with Hodgkin’s Lymphoma and thanked her loyal dog, Murph, for comforting her ...

Tandem-target CAR-T produced a response in all participants with relapsed or refractory mantle cell lymphoma in a phase 1/2 study. Patients received their CAR-T within 8 to 12 days of lymphodepletion.

Apr. 29, 2025 — A Phase I trial involving ten patients with relapsed or refractory classical Hodgkin lymphoma or T-cell lymphoma has achieved a 100% overall response rate and a 50% complete ...

Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.

A new animal welfare volunteer team has been launched in a bid to protect the 250 police dogs working for West Midlands Police A new animal welfare volunteer scheme has been launched as part of ...

The Dangerous Dogs Act (1991) was introduced in the UK following a series of serious, and in some cases fatal, dog attacks on humans. The Act has been widely discredited for failing to address the ...